H1N1 "Swine Flu" Panvax Training Presentation Received by Health Care Workers in Australia (Contains Vaccine Ingredient List)!

If you are looking for the official Panvax® product information sheet that includes the vaccine's ingredients --> Click this link from Health Links.

H1N1 Panvax Training Presentation for Australian Health Care Workers

The most important aspect of this presentation in my opinion is the vaccine ingredient list that appears on Slides 16-23. Panvax allegedly does not have adjuvants, but it appears to have all the other ingredients that have been previously reported on this site. Also, why are there witches brewing up this vaccine in the presentation slide?

Infowars has also listed the following provisions of note:

Slide 3: Refers to targeted groups as herds.

Slides 4 & 5: Lists of priority tiers

Slide 16: What is Panvax? (Note image from presentation below)

Slides 18 to 24: Lists ingredients including thiomersal.

Slide 19: Admits that it causes toxic effects.

Slide 25: “Previously — The vaccination course consists of 2 doses of 15ug of antigen at least 21 days apart…. This now no longer applies. The vaccination course consists of 1 dose of 15ug of antigen for those aged 9 years of age and older.”

Slide 26: “Children aged 6 months to (9 years of age require 2 doses with a minimal interval of 21 days).”

Slide 28: Recommends that children under 10 wait for the “thiomersal free vaccine,” however Slide 20 says “There is no evidence that thiomersal has caused any developmental or neurological abnormalities, such as ADHD or Autism.”

Slide 47: Shows picture of heavily armed police and ties them to vaccine protection.

Slides 57 to 61: Section titles “Who should not get the vaccine?”

Slides 66 & 67: List Guillian-Barre Syndrome (GBS) as vaccine side effect.

Slides 76 & 77: Talks about consent. There is plenty of food for thought about the vaccines, according to Dr. Mayer Eisenstein, (see his Don’t Vaccinate! Before You Educate.)

From the CSL website: The CSL Group has a combined heritage of outstanding contribution to medicine and human health with more than 90 years experience in the development and manufacture of vaccines and plasma protein biotherapies. With major facilities in Australia, Germany, Switzerland and the US, CSL has over 10,000 employees working in 27 countries.

Source: Infowars